Actively Recruiting
Diagnosis of Transient Ischemic Attacks in the Emergency Department
Led by University Hospital, Strasbourg, France · Updated on 2026-01-14
300
Participants Needed
1
Research Sites
N/A
Total Duration
On this page
AI-Summary
What this Trial Is About
Researchers are studying patients who have experienced a Transient Ischemic Attack (TIA) and who are admitted to the Emergency Department. The study aims to understand how patients with TIA are managed in terms of examinations, treatments, and specialist referrals, especially considering that not all patients may need neurovascular expertise. This observational study is conducted by the University Hospital in Strasbourg, France, and addresses concerns about unequal access to specialized care and whether current management aligns with patients' cardiovascular risk. The study observes the current care practices for TIA patients who visited the Emergency Department between January 1, 2024, and December 12, 2024. It does not involve assigning treatments but collects information to evaluate how diagnostic and therapeutic interventions correspond to patients' risk. The researchers particularly focus on whether additional examinations, treatments, and referrals are appropriately linked to cardiovascular risk. Participants will be followed up for up to 12 months, during which the main outcome measure is the ABCD2 score, a tool used to assess the risk of stroke after a TIA. Data collection includes reviewing medical records and monitoring cardiovascular events. The study does not involve any experimental treatments, but it monitors participant outcomes to better understand care quality and risks associated with TIA management over time.
CONDITIONS
Brief Title
Diagnosis of Transient Ischemic Attacks in the Emergency Department
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Adult (≥18 years old)
- Consulted the emergency department or diagnosed with TIA between January 1, 2024, and December 12, 2024
- TIA defined as a sudden, transient neurological deficit resolved by the time of arrival at the emergency department
You will not qualify if you...
- Suspected diagnosis of TIA without confirmed sudden, transient neurological deficit resolved by arrival at the emergency department
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Your Study Journey
Duration - 2 to 4 weeks
Participants are screened for eligibility to participate in the trial.
1 visit (in-person)
Duration - Up to 1 day
Participants undergo diagnostic evaluation for transient ischemic attacks in the emergency department.
1 visit (in-person)
Duration - Up to 12 months
Participants are monitored for up to 12 months to assess the ABCD2 score and related outcomes.
Periodic visits up to 12 months
Trial Site Locations
Total: 1 location
1
Service d'Urgences Médico-Chirurgicales Adules - CHU de Strasbourg - France
Strasbourg, France, 67091
Actively Recruiting
Research Team
P
Pierrick LE BORGNE, MD
M
Mathieu OBERLIN, MD
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
0
Similar Trials
Frequently Asked Questions
Have more questions? Get in touch with our team for quick support
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here